Brand Name | Status | Last Update |
---|---|---|
granix | Biologic Licensing Application | 2023-11-30 |
neupogen | Biologic Licensing Application | 2024-10-30 |
nivestym | Biologic Licensing Application | 2024-02-28 |
nypozi | Biologic Licensing Application | 2024-12-18 |
releuko | Biologic Licensing Application | 2023-08-25 |
zarxio | Biologic Licensing Application | 2024-10-25 |
Expiration | Code | ||
---|---|---|---|
filgrastim, Neupogen, Amgen Inc. | |||
2122-03-30 | Orphan excl. | ||
filgrastim, Granix, UAB Teva Baltics | |||
2024-08-29 | Reference product excl. |
Code | Description |
---|---|
J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram |
J1447 | Injection, tbo-filgrastim, 1 microgram |
J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram |
Q5108 | Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg |
Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram |
Q5111 | Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg |
Q5120 | Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg |
Q5122 | Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 4 | 2 | — | 2 | 8 |
Leukemia | D007938 | — | C95 | 1 | 1 | 2 | — | — | 4 |
Myeloid leukemia | D007951 | — | C92 | 1 | 1 | 1 | — | — | 3 |
Myelodysplastic syndromes | D009190 | — | D46 | — | — | 2 | — | — | 2 |
Preleukemia | D011289 | — | — | — | — | 2 | — | — | 2 |
Syndrome | D013577 | — | — | — | — | 2 | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | — | 1 | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | — | — | 1 | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 1 | 7 | — | — | 1 | 8 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 5 | — | — | 1 | 6 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 3 | — | — | 1 | 5 |
Lung neoplasms | D008175 | — | C34.90 | — | 3 | — | — | 1 | 4 |
Sarcoma | D012509 | — | — | 1 | 2 | — | — | — | 3 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 3 | — | — | — | 3 |
Plasma cell neoplasms | D054219 | — | — | 1 | 3 | — | — | — | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 2 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 2 |
Hodgkin disease | D006689 | — | C81 | — | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Aids-related complex | D000386 | EFO_0007137 | B20 | 1 | — | — | — | 1 | 2 |
Immunologic deficiency syndromes | D007153 | — | D84.9 | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | — | — | — | — | 1 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
Germ cell and embryonal neoplasms | D009373 | — | — | 1 | — | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Nervous system neoplasms | D009423 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Graft vs host disease | D006086 | — | D89.81 | — | — | — | — | 1 | 1 |
Drug common name | Filgrastim |
INN | filgrastim |
Description | Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause. It may also be used to increase white blood cells for gathering during leukapheresis. It is given either by injection into a vein or under the skin.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201567 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00099 |
UNII ID | PVI5M0M1GW (ChemIDplus, GSRS) |